Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Therapeutic Advances in Childhood Leukemia Consortium
Columbia University
Massachusetts General Hospital
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
University of California, San Francisco
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
City of Hope Medical Center
Alliance for Clinical Trials in Oncology
Columbia University
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine
UNC Lineberger Comprehensive Cancer Center
University of Southern California
M.D. Anderson Cancer Center
Gustave Roussy, Cancer Campus, Grand Paris
M.D. Anderson Cancer Center
New Mexico Cancer Research Alliance
Washington University School of Medicine
Georgetown University
Emory University
University of Chicago
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Washington University School of Medicine
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
The University of Texas Health Science Center at San Antonio
University of California, Davis
Massachusetts General Hospital